ArticleOncotarget2018
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.
Mohamad Elbaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled itcites it
ArticleOncotarget2018
Mohamad Elbaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.